These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26117538)

  • 81. Genomic structure and expression of Jmjd6 and evolutionary analysis in the context of related JmjC domain containing proteins.
    Hahn P; Böse J; Edler S; Lengeling A
    BMC Genomics; 2008 Jun; 9():293. PubMed ID: 18564434
    [TBL] [Abstract][Full Text] [Related]  

  • 82. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma.
    Wong M; Sun Y; Xi Z; Milazzo G; Poulos RC; Bartenhagen C; Bell JL; Mayoh C; Ho N; Tee AE; Chen X; Li Y; Ciaccio R; Liu PY; Jiang CC; Lan Q; Jayatilleke N; Cheung BB; Haber M; Norris MD; Zhang XD; Marshall GM; Wang JY; Hüttelmaier S; Fischer M; Wong JWH; Xu H; Perini G; Dong Q; George RE; Liu T
    Nat Commun; 2019 Jul; 10(1):3319. PubMed ID: 31346162
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Propagation of adipogenic signals through an epigenomic transition state.
    Steger DJ; Grant GR; Schupp M; Tomaru T; Lefterova MI; Schug J; Manduchi E; Stoeckert CJ; Lazar MA
    Genes Dev; 2010 May; 24(10):1035-44. PubMed ID: 20478996
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CEBPβ binding directly to the promoter region drives CEBPɑ transcription and improves FABP4 transcriptional activity in adipose tissue of yak (Bos grunniens).
    Gui L; Raza SHA; Ma B; Easa AA; Althobaiti F; Shukry M; Alotaibi MA; Al Hazani TMI; Dawood MAO; Khan R; Jahejo AR; Shater AF; Abd El-Aziz AH; Quan G; Alanbari KH; Wang L
    Res Vet Sci; 2021 Dec; 141():174-179. PubMed ID: 34749102
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeted erasure of DNA methylation by TET3 drives adipogenic reprogramming and differentiation.
    Park J; Lee DH; Ham S; Oh J; Noh JR; Lee YK; Park YJ; Lee G; Han SM; Han JS; Kim YY; Jeon YG; Nahmgoong H; Shin KC; Kim SM; Choi SH; Lee CH; Park J; Roh TY; Kim S; Kim JB
    Nat Metab; 2022 Jul; 4(7):918-931. PubMed ID: 35788760
    [TBL] [Abstract][Full Text] [Related]  

  • 86. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation.
    Wang F; He L; Huangyang P; Liang J; Si W; Yan R; Han X; Liu S; Gui B; Li W; Miao D; Jing C; Liu Z; Pei F; Sun L; Shang Y
    PLoS Biol; 2014 Mar; 12(3):e1001819. PubMed ID: 24667498
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Waves of sumoylation support transcription dynamics during adipocyte differentiation.
    Zhao X; Hendriks IA; Le Gras S; Ye T; Ramos-Alonso L; Nguéa P A; Lien GF; Ghasemi F; Klungland A; Jost B; Enserink JM; Nielsen ML; Chymkowitch P
    Nucleic Acids Res; 2022 Feb; 50(3):1351-1369. PubMed ID: 35100417
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6.
    Cockman ME; Sugimoto Y; Pegg HB; Masson N; Salah E; Tumber A; Flynn HR; Kirkpatrick JM; Schofield CJ; Ratcliffe PJ
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2201483119. PubMed ID: 35930668
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of lncRNA LIPE-AS1 in adipogenesis.
    Thunen A; La Placa D; Zhang Z; Shively JE
    Adipocyte; 2022 Dec; 11(1):11-27. PubMed ID: 34957921
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo.
    Xiao RQ; Ran T; Huang QX; Hu GS; Fan DM; Yi J; Liu W
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2200753119. PubMed ID: 35969736
    [TBL] [Abstract][Full Text] [Related]  

  • 91. JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets.
    Raguz N; Heim A; Engal E; Wesche J; Merl-Pham J; Hauck SM; Erkelenz S; Schaal H; Bensaude O; Wolf A; Salton M; Böttger A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927736
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response.
    Wang K; Yang C; Li H; Liu X; Zheng M; Xuan Z; Mei Z; Wang H
    Front Immunol; 2022; 13():859893. PubMed ID: 35359945
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer.
    Zheng H; Tie Y; Fang Z; Wu X; Yi T; Huang S; Liang X; Qian Y; Wang X; Pi R; Chen S; Peng Y; Yang S; Zhao X; Wei X
    Signal Transduct Target Ther; 2019; 4():24. PubMed ID: 31637004
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.
    Denis GV; Nikolajczyk BS; Schnitzler GR
    FEBS Lett; 2010 Aug; 584(15):3260-8. PubMed ID: 20493850
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinB12 in transcriptional regulation.
    Chen J; Kuhn LA
    J Mol Graph Model; 2019 Jul; 90():59-76. PubMed ID: 31026779
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor.
    Jablonowski C; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J
    bioRxiv; 2023 Nov; ():. PubMed ID: 37425900
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A constitutional isomer selective chemical proteomic strategy for system-wide profiling of protein lysine 5-hydroxylation.
    Sin YC; Park M; Griffin TJ; Yong J; Chen Y
    Chem Sci; 2024 Oct; ():. PubMed ID: 39421203
    [TBL] [Abstract][Full Text] [Related]  

  • 98. JmjC Domain-containing Protein 6 (Jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-like 1 (Tcf7l1) and Is Required for Body Axis Patterning during Xenopus Embryogenesis.
    Zhang X; Gao Y; Lu L; Zhang Z; Gan S; Xu L; Lei A; Cao Y
    J Biol Chem; 2015 Aug; 290(33):20273-83. PubMed ID: 26157142
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling.
    Tikhanovich I; Kuravi S; Artigues A; Villar MT; Dorko K; Nawabi A; Roberts B; Weinman SA
    J Biol Chem; 2015 Sep; 290(36):22236-49. PubMed ID: 26221041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.